Mutations can take many different forms, such as chromosomal rearrangements, variations in the number of chromosomes, and gene (point) mutations. These changes can be found in both mammalian and bacterial cells, frequently by microscopic examination or growth needs. To ensure safety, it is crucial to evaluate a chemical’s mutagenic potential. One popular technique in toxicology is the Ames test. This bacterial gene mutation assay, created by Bruce N. Ames in 1975, is robust, dependable, and reasonably priced. To discover reverse mutations that restore their capacity to generate critical amino acids, it uses strains of Salmonella typhimurium or Escherichia coli that have been modified to be amino acid-dependent. The plate incorporation assay and the preincubation assay are the two main methods used in the Ames test. While the preincubation assay necessitates a preparatory incubation step before plating, the plate integration method mixes the test substance with bacteria and an S9 metabolic activation system before plating. By assessing the development of revertant colonies, these assays shed light on the mutagenic qualities of substances. Standardized procedures have been set up by international regulatory organizations like the Organization for Economic Co-operation and Development (OECD) and International Council for Harmonization (ICH) to guarantee uniformity in mutagenicity evaluations. The test makes use of particular bacterial strains that are intended to identify various changes, such as frameshift and base-pair substitution mutations. The Ames test continues to be a fundamental component of genetic toxicology, aiding in the assessment of industrial chemicals, medicines, and environmental agents by offering a trustworthy screening method for chemical mutagenicity.